Monrovia – Health authorities in Liberia have confirmed four active Monkeypox cases as the country ramps up its response to contain the outbreak. The Ministry of Health, in partnership with the National Public Health Institute of Liberia (NPHIL), made the announcement during a press briefing on Sunday.
By Edwin G. Genoway, Jr. | [email protected]
Dr. Dougbeh Chris Nyan, Director-General of NPHIL, disclosed that from January 1, 2024, to May 11, 2025, Liberia has reported 652 suspected cases of Monkeypox. Of these, 572 samples were tested, resulting in 78 confirmed infections. No deaths have been recorded in Liberia, in contrast to neighboring Sierra Leone, which has reported 13 Monkeypox-related fatalities.
“The situation is being actively managed, and we are leveraging both modern and traditional medical interventions,” Dr. Nyan said. He added that Liberia’s approach to surveillance has been praised by the Africa Centres for Disease Control and Prevention (Africa CDC) as a model for regional health management.
Dr. Nyan also introduced the “717 Procedure,” a strategic public health initiative designed to identify, test, and manage all Monkeypox cases within seven days of detection.
“Timeliness is critical in managing outbreaks, and this framework will help strengthen our national response,” he emphasized.
He confirmed that all samples were tested in nationally certified labs, reflecting Liberia’s increasing diagnostic capacity. The country has also enhanced budgetary support for outbreak response, backed by both national lawmakers and international partners, including the WHO and Africa CDC.
In light of recent rumors circulating online, Dr. Nyan thanked the media for maintaining professionalism and avoiding the spread of misinformation. He clarified that the press conference was prompted by renewed public interest following a confirmed case that recently gained attention.
Dr. Nyan highlighted the role of a prominent Liberian celebrity who publicly shared his Monkeypox diagnosis and recovery. The individual’s openness has helped to reduce public stigma, encourage testing, and promote vaccine acceptance.
“He is playing a vital role in promoting awareness without inciting panic,” said Dr. Nyan, noting the positive impact on national health messaging.
Liberia received Monkeypox vaccines from the Africa CDC in late 2024. Since then, more than 2,000 individuals—including close contacts and high-risk populations—have been vaccinated across four counties.
Vaccination in Montserrado County is expected to begin soon, targeting exposed individuals. Dr. Nyan clarified that the vaccine is not yet available for general public use but remains focused on those most at risk.
Dr. Nyan urged citizens to remain vigilant and watch for symptoms such as fever, rash, and headaches. Suspected cases should be reported immediately to local health authorities.
As Liberia continues to manage the outbreak, Dr. Nyan reaffirmed the government’s commitment to sustained testing, community education, and global cooperation.
“We have shown that with coordinated efforts, transparency, and community involvement, outbreaks can be managed effectively,” he added.